INS and Hypoglycemia: When initiating SGLT2 inhibitors in patients already on insulin with HbA1c < 58 mmol/mol and eGFR > 45 mL/min/1.73 m2, consider reducing the insulin dose by 20% to avoid hypoglycemia [59].